Home / Inspections / 915621

FDA Inspection 915621 — Catalent Belgium SA

Catalent Belgium SA — FEI 3007647000

The FDA completed an inspection of Catalent Belgium SA on February 13, 2015 in Brussels. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 13, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brussels (Belgium)

Facility

Other inspections at this facility

  • 1246550 (VAI Fri Apr 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1177876 (VAI Fri Aug 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1136201 (VAI Wed Jan 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093395 (VAI Wed Jun 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1061068 (NAI Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources